UTI Healthcare Fund vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
UTI Healthcare Fund - Regular Plan - Growth Option
Chart Comparison
Overview
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹233 Cr | ₹1125 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 08 Nov 2021 | 30 Jul 2005 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
| Turn Over | % | 28% |
| Expense Ratio | 2.35 | 2.22 |
| Manager | Rohan Korde | Kamal Gada |
| ISIN Code | INF00XX01BL5 | INF789F01695 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | UTI Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Month | -2.61% | -1.36% |
| 6 Month | 0.49% | 4.67% |
| 1 Year | -4.82% | 0.82% |
| 3 Year | 18.66% | 23.63% |
| 5 Year | - | 17.06% |
SIP Return Analysis
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 6 Month | -1.91% | -1.2% |
| 1 Year | -1.31% | 4.98% |
| 3 Year | 15.54% | 20.89% |
| 5 Year | - | 18.42% |
Rolling Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Year | 18.94% | 11.68% |
| 3 Year | 20.21% | 16.52% |
| 5 Year | - | 14.75% |
Risk Management
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Standard Deviation | 15.64% | 15.78% |
| Sharp | 0.77% | 1.03% |
| Beta | 0.95% | 0.95% |
| Alpha | -2.74% | 1.30% |
Fund Managers
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Name | Rohan Korde | Kamal Gada |
| Total AUM | ₹4626 Cr | ₹870 Cr |
| Funds Managed | 10 | 1 |
| ITI Pharma and Healthcare Fund Regular - Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
Market Cap
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 3.94 | 4.96 |
| Large Cap | 32.04 | 21.02 |
| Mid Cap | 36.31 | 34.42 |
| Small Cap | 27.72 | 39.6 |
Sector Allocation
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 1.7 | 1.88 |
| Healthcare | 93.14 | 97.05 |
| Basic Materials | 2.87 | 1.08 |
| Industrials | 1.05 | - |
| Financial Services | 1.25 | - |
Top Comparisons
BANDHAN Asset Allocation Fund - Regular Plan - Aggressive Plan - Growth
3Y Returns13.81%
Nippon India Multi Asset Omni FOF - Regular Plan - Growth
3Y Returns19.57%
Franklin U.S. Opportunities Equity Active FOF - Regular - Growth
3Y Returns22.48%
Invesco India - Invesco Pan European Equity Fund of Fund - Regular Plan - Growth Option
3Y Returns15.28%
HSBC Credit Risk Fund - Regular Growth
3Y Returns11.17%
Baroda BNP Paribas Credit Risk Fund -Regular-Growth Option
3Y Returns7.89%
ICICI Prudential Silver ETF Fund of Fund - Growth
3Y Returns33.56%
HDFC Silver ETF Fund of Fund - Growth Option
3Y Returns34.01%